Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.
- DOI
- 10.1016/j.cct.2021.106346
- Published
- 2021 May
- Container
- Contemporary clinical trials
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cct.2021.106346,
title = {Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.},
author = {Monti G and Galbiati C and Toffoletto F and Calabrò MG and Colombo S and Ferrara B and Giardina G and Lembo R and Marzaroli M and Moizo E and Mucci M and Pasculli N and Plumari VP and Scandroglio AM and Tozzi M and Momesso E and Boffa N and Lobreglio R and Montrucchio G and Guarracino F and Benedetto U and Biondi-Zoccai G and D'Ascenzo F and D'Andrea N and Paternoster G and Ananiadou S and Ballestra M and De Sio A and Pota V and Cotoia A and Della Selva A and Bruni A and Iapichino G and Bradić N and Corradi F and Gemma M and Nogtev P and Petrova M and Agrò FE and Cabrini L and Forfori F and Likhvantsev V and Bove T and Finco G and Landoni G and Zangrillo A and Collaborators},
year = {2021},
journal = {Contemporary clinical trials},
doi = {10.1016/j.cct.2021.106346},
url = {https://doi.org/10.1016/j.cct.2021.106346}
}RIS
TY - JOUR TI - Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design. AU - Monti G AU - Galbiati C AU - Toffoletto F AU - Calabrò MG AU - Colombo S AU - Ferrara B AU - Giardina G AU - Lembo R AU - Marzaroli M AU - Moizo E AU - Mucci M AU - Pasculli N AU - Plumari VP AU - Scandroglio AM AU - Tozzi M AU - Momesso E AU - Boffa N AU - Lobreglio R AU - Montrucchio G AU - Guarracino F AU - Benedetto U AU - Biondi-Zoccai G AU - D'Ascenzo F AU - D'Andrea N AU - Paternoster G AU - Ananiadou S AU - Ballestra M AU - De Sio A AU - Pota V AU - Cotoia A AU - Della Selva A AU - Bruni A AU - Iapichino G AU - Bradić N AU - Corradi F AU - Gemma M AU - Nogtev P AU - Petrova M AU - Agrò FE AU - Cabrini L AU - Forfori F AU - Likhvantsev V AU - Bove T AU - Finco G AU - Landoni G AU - Zangrillo A AU - Collaborators PY - 2021 JO - Contemporary clinical trials DO - 10.1016/j.cct.2021.106346 UR - https://doi.org/10.1016/j.cct.2021.106346 ER -
APA
G, M., C, G., F, T., MG, C., S, C., B, F., G, G., R, L., M, M., E, M., M, M., N, P., VP, P., AM, S., M, T., E, M., N, B., R, L., G, M., F, G., U, B., G, B., F, D., N, D., G, P., S, A., M, B., A, D. S., V, P., A, C., A, D. S., A, B., G, I., N, B., F, C., M, G., P, N., M, P., FE, A., L, C., F, F., V, L., T, B., G, F., G, L., A, Z., & Collaborators (2021). Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.. Contemporary clinical trials. https://doi.org/10.1016/j.cct.2021.106346
Source records
- pubmed · retrieved 2026-09-26T15:54:58.531Z
- europe-pmc · retrieved 2026-09-26T15:54:58.530Z